| Contents |
Alcohol: pharmacokinetics, health benefits with moderate consumption and toxicity / Amitava Dasgupta -- Alcohol analysis in various matrixes: clinical versus forensic testing / Steven C. Kazmierzak -- Alcohol biomarkers: clinical issues and analytical methods / Joshua A. Bornhorst, Michael M. Mbughuni -- Genetic markers related to alcohol use and abuse / Joshua A. Bornhorst, Gwendolyn McMillin -- Ethylene glycol and other glycols: analytical and interpretation issues / Uttam Garg, Jennifer Lowry, D. Adam Algren -- Introduction to drugs of abuse / Loralie J. Langman, Christine L.H. Snozek -- Legal aspects of drug testing in US military and civil courts / John F. Jemionek, Marilyn R. Past -- Pharmacogenomics of drugs of abuse / Christine L.H. Snozek, Loralie J. Langman -- Immunoassay design for screening of drugs of abuse / Pradip Datta -- Issues of interferences with immunoassays used for screening of drugs of abuse in urine / Anu S. Maharjan, Kamisha L. Johnson-Davis -- Point of care devices for drugs of abuse testing: limitations and pitfalls / Veronica Luzzi -- Drugs of abuse screening and confirmation with lower cutoff values / Albert D. Fraser -- Overview of analytical methods in drugs of abuse analysis: gas chromatography/mass spectrometry, liquid chromatography combined with tandem mass spectrometry and related methods / Alec Saitman -- High-resolution mass spectometry: an emerging analytical method for drug testing / Michelle Wood -- Confirmation methods for SAMHSA drugs and other commonly abused drugs / Justin Holler, Barry Levine -- Critical issues when testing for amphetamine-type stimulants: pitfalls of immunoassay screening and mass spectrometric confirmation for amphetamines, methamphetamines, and designer amphetamines / Larry Broussard -- Cocaine, crack cocaine and ethanol: a deadly mix / Eric T. Shimomura, George F. Jackson, Buddha Dev Paul -- Drug assisted sexual assaults: toxicology, fatality and analytical challenge / Matthew D. Krasowski -- Overview of common designer drugs / Lilian H.J. Richter, Markus R. Meyer, Hans H. Maurer -- New psychoactive substances: an overview / Laura Mercolini -- Review of bath salts on illicit drug market / Michele Protti -- Review of synthetic cannabinoids on illicit drug market / Mahmoud A. ElSohly, Sohail Ahmed, Shahbaz W. Gul, Waseem Gul -- Application of liquid chromatography combined with high resolution mass spectrometry for urine drug testing / Olef Bek, Alexia Rylski, Niclas Nikolai Stephanson -- Forensic toxicology in death investigation / Hannah Kastenbaum, Lori Proe, Lauren Dvorscak -- Drug testing in pain management / Gary M. Reisfield, Roger L. Bertholf -- How do people try to beat drugs test? Effects of synthetic urine, substituted urine, diluted urine and in vitro urinary adulterants on drugs of abuse testing / Shanlin Fu -- When hospital toxicology report is negative in a suspected overdosed patient: strategy of comprehensive drug screen using liquid chromatography combined with mass spectrometry / Ernest D. Lykissa -- Testing of drugs in oral fluid, sweat, hair and nail: analytical, interpretative and specimen adulteration issues / Uttam Garg, Carl Cooley -- Advances in meconium analysis for assessment of neonatal drug exposure / Steven W. Cotten -- Analytical true positive drug tests due to use of prescription and non-prescription medications / Matthew D. Krasowski, Tai C. Kwong -- Analytical true positive: poppy seed products and opiate analysis / Amitava Dasgupta -- Miscellaneous issues: paper money contaminated with cocaine and other drugs, cocaine containing herbal teas, passive exposure of marijuana, ingestion of hemp oil and occupational exposure to controlled substances / Amitava Dasgupta -- Abuse of magic mushroom, peyote cactus, LSD, khat, and volatiles / Amitava Dasgupta -- Performance enhancing drugs in sports / Brian D. Ahrens, Anthony W. Butch. |
| Abstract |
Critical Issues in Alcohol and Drugs of Abuse Testing, Second Edition, addresses the general principles and technological advances for measuring drugs and alcohol, along with the pitfalls of drugs of abuse testing. Many designer drugs, for example, are not routinely tested in drugs of abuse panels and may go undetected in a drug test. This updated edition is a must-have for clinical pathologists, toxicologists, clinicians, and medical review officers and regulators, bridging the gap between technical and clinical information. Topics of note include the monitoring of pain management drugs, bath salts, spices (synthetic marijuana), designer drugs and date rape drugs, and more. |
